bupropion

gcolor="#ffffff" align="center" colspan=2\| Bupropion
lign="center" colspan=2 style="border-bottom:3px solid gray;"\|()-1-(3-chlorophenyl)-2-(1,1-dimethylethyl)amino-1-propanone
gcolor="#efefef"\|Empiric formula	bgcolor="#dfefff"\|C₁₃H₁₈Cl N O
gcolor="#efefef"\|Molecular weight	bgcolor="#dfefff"\|239.74
gcolor="#efefef"\|Bioavailability	bgcolor="#dfefff"\|?
gcolor="#efefef"\|Metabolism	bgcolor="#dfefff"\|Liver
gcolor="#efefef"\|Elimination half life	bgcolor="#dfefff"\|20 hours
gcolor="#efefef"\|Excretion	bgcolor="#dfefff"\|Urine
gcolor="#efefef"\|ATC code	bgcolor="#dfefff"\|N07BA02
gcolor="#efefef"\| Pregnancy category	bgcolor="#dfefff"\|B (USA) ? (Aus)

Bupropion (amfebutamone) is an antidepressant of the amino ketone class, chemically unrelated to tricyclics or SSRIs. It is similar in structure to the stimulant cathinone, and to phenethylamines in general.

History

Bupropion was first synthesized by Burroughs Research in 1966, and patented by Burroughs-Wellcome (later Glaxo-Wellcome) in 1974. It was approved by the FDA in 1985 and marketed under the name Wellbutrin as an antidepressant, but clinical trials indicated that incidence of seizure was two to four times greater than other antidepressants and the drug was quickly pulled from the market. Glaxo, realizing that seizure risk was a function of dosage, then developed and marketed a sustained-release (SR) version of Wellbutrin which, when ingested, releases bupropion hydrochloride at a constant, gradual rate into the body. Because of this altered mechanism of delivery, incidence of seizure with Wellbutrin-SR is comparable to, and in some cases, lower than that of other antidepressants. In 1997, bupropion HCl was approved by the FDA for use as a smoking cessation aid. Because the name Wellbutrin was still associated with high seizure risk, the drug was subsequently marketed by Glaxo under the name Zyban to help people stop smoking tobacco by reducing the severity of withdrawal symptoms. It can be used in combination with nicotine replacement therapies. Bupropion treatment course lasts for seven to twelve weeks, the patient halting the use of tobacco around ten days into the course. It is contraindicated in people taking medication for seizure disorders (phenytoin, phenobarbital), with bulimia or anorexia, with kidney or liver dysfunctions, or people already taking any monoamine oxidase inhibitor. It can also cause problems with cold remedies, certain herbal supplements, creatine, cimetidine, ephedrine, and benzodiazepines.

Mode of action

Bupropion is a selective catecholamine (norepinephrine and dopamine) reuptake inhibitor. It has only a small effect on serotonin reuptake. It does not inhibit MAO. The actual mechanism behind bupropion's action is not known, but it is thought to be due to the effects on dopaminergic and noradrenergic mechanisms.

Pharmacokinetics

Bupropion is metabolised in the liver. It has at least three active metabolites; hydroxybupropion, threohydrobupropion and erythrohydrobupropion. These active metabolites are further metabolised to inactive metabolites and eliminated through excretion into the urine. The half-life of bupropion is 20 hours as is hydroxybupropion's. Threohydrobupropion's half-life is 37 hours and erythrohydrobupropion's 33 hours.

Pills

Wellbutrin pills are available in three forms: immediate release, sustained release (SR) and extended release (XL). Generic forms of immediate and sustained release are available. Brand Name>

lign="center" bgcolor=#cccccc\|Dosage	align="center" bgcolor=#cccccc\|Color
lign="center" bgcolor=#F5F5F5\|Wellbutrin	align="center" bgcolor=#F5F5F5\|75 mg	align="center" bgcolor="#FFFF99"\|yellow-gold
lign="center" bgcolor=#F5F5F5\|Wellbutrin	align="center" bgcolor=#F5F5F5\|100 mg	align="center" bgcolor="#FF6666"\|red
lign="center" bgcolor=#F5F5FF\|Wellbutrin SR	align="center" bgcolor=#F5F5FF\|100 mg	align="center" bgcolor="#99CCFF"\|blue
lign="center" bgcolor=#F5F5FF\|Wellbutrin SR	align="center" bgcolor=#F5F5FF\|150 mg	align="center" bgcolor="#CC99FF"\|purple
lign="center" bgcolor=#F5F5FF\|Wellbutrin SR	align="center" bgcolor=#F5F5FF\|200 mg	align="center" bgcolor="#FF99BB"\|pink
lign="center" bgcolor=#F5FFF5\|Wellbutrin XL	align="center" bgcolor=#F5FFF5\|150 mg	align="center"\|white
lign="center" bgcolor=#F5FFF5\|Wellbutrin XL	align="center" bgcolor=#F5FFF5\|300 mg	align="center"\|white
lign="center" bgcolor=#FFF5F5\|Zyban	align="center" bgcolor=#FFF5F5\|??? mg	align="center" bgcolor="#CC99FF"\|???
lign="center" bgcolor=#FFF5F5\|Zyban SR	align="center" bgcolor=#FFF5F5\|150 mg	align="center" bgcolor="#CC99FF"\|purple

Side effects

Common side effects include dry mouth, tremors, anxiety, loss of appetite, agitation, dizziness, headache, excessive sweating, increased risk of seizure, and insomnia. Bupropion causes less insomnia if it is taken just before going to bed.

External links

<< Previous

Word Browser

Next >>

bundesstelle fr flugunfalluntersuchung
faust (movie)
united states forces japan
kurt diemberger
nusch eluard
air accidents investigation branch
san jose state university
wooton desk
juan valdez
apop
rocket from the tombs

cerebral edema
gospel according to the hebrews
buildprofessional
brendan canty
papyrology
shudder to think
whitehead institute
pinko
water vascular system
eric harris and dylan klebold
money and the ethnic vote

joey shithead
sudden death records
hydrozoa
grand duchy of poznan
obelia
president of angola
danny ainge
tunicate
list of presidents of benin
heads of state of botswana
bill the cat

heads of state of burkina faso
cassie bernall
list of kings of burundi
opus the penguin
war elephant
heads of state of cameroon
bee anatomy (mouth)
advanced authoring format
heads of state of cape verde
honeybee life cycle
aaf